Skip to content
Options Trading Report

Options Trading Report

Primary Menu
  • Home
  • Business
  • Economy
  • Top News
  • Newsletters
  • Home
  • 2026
  • August
  • When AI Capex Pays: The Case for MSFT at $492
  • Business

When AI Capex Pays: The Case for MSFT at $492

Azure's 43% growth quarter ended a year-long debate. Now ask whether the market has already priced it in.
Editor August 30, 2026 4 minutes read
f536df22-932b-451b-8835-5499055eb1d9

For most of fiscal 2026, Microsoft beat earnings estimates and watched the stock fall. Three times in a row, a solid quarter produced a negative reaction, because investors had grown skeptical that billions in AI infrastructure spending would ever show up as actual revenue. Coming into the July 29 report, MSFT had fallen roughly 19% year-to-date, as investors grew skeptical about whether massive AI capital expenditures would translate into tangible revenue growth. Prior quarters saw strong beats followed by negative stock reactions. That pattern collapsed on July 29.

Microsoft’s fiscal fourth-quarter report triggered a record near-$450 billion market-cap surge the next day, driven by revenue of $90.0 billion and adjusted EPS of $4.74, both exceeding consensus. The headline number that mattered: Azure and other cloud services revenue increased 43% year-over-year, while Microsoft Cloud revenue reached $59.3 billion, up 27%. Critically, management guided Azure growth to approximately 45% in constant currency for the current quarter, with first-half fiscal 2027 growth expected to accelerate further.

The Business

Microsoft’s AI monetization is no longer a promise. The figure that changes the investment calculus is the AI run rate: management disclosed that the AI business has reached a $37 billion annual revenue run rate, up 123% from a year earlier. That is not capex. That is booked revenue at scale.

Developer engagement is surging, with GitHub reaching 225 million developers and GitHub Copilot climbing to 50 million users. After shifting to usage-based billing, Copilot revenue accelerated more than 60% quarter over quarter. Meanwhile, commercial remaining performance obligation climbed 84% to $678 billion, indicating a substantial backlog of committed revenue. That backlog removes a lot of the speculation from the bull case.

Why Wall Street Is Paying Attention

The Mag 7 stocks gained 2.2% last week, with Microsoft leading the group and offering what one market observer called hope for an AI capex payday. Microsoft shares trade near $492. That move restored a stock that spent most of the year in the $390 to $500 range to a position of genuine technical strength.

Institutional conviction is backing the move. 42 of 47 analysts covering Microsoft hold Buy ratings, with 5 rating the stock as Hold and none assigning a Sell. JPMorgan raised its December 2027 price objective to $625, highlighting Azure and Copilot monetization. Wells Fargo sits at $700, Sanford Bernstein at $660, and Royal Bank of Canada at $640.

What’s Driving the Opportunity

Operating income reached $40.60 billion, up 18% year-over-year, with operating margin of 45.1%. That margin held even as AI workload costs rose, which is the data point bears had been waiting to see fail. As MSFT converts AI infrastructure investments into higher Azure consumption, stronger software monetization, and larger contracted revenue, the economics of that spending should become increasingly attractive.

First-quarter Azure growth is guided to roughly 45% in constant currency, and CFO Amy Hood stated plainly that “demand continues to exceed available supply.” When the constraint on your highest-growth segment is capacity rather than demand, that is a fundamentally different risk profile than the market priced for most of the year.

What Could Go Wrong

The honest question here is valuation after a big move. The trailing and forward PE figures move with price and estimates, and they vary depending on the data source and timestamp. That is below Microsoft’s own 10-year average multiple, which is one argument for continued expansion. But momentum indicators suggest the advance is stretched, with the RSI reading around 70.5 having moved into overbought territory. A consolidation from here would not be unusual, and anyone buying now is not buying the earnings dip.

Even with efficiency gains, the company acknowledged that rapid AI adoption brings near-term gross margin pressure as workloads scale. For fiscal 2027, Microsoft guided to operating margins dipping by less than one point. And free cash flow, at $19.6 billion for the quarter, fell 23% as capex consumed the difference. That figure will matter again if Azure growth shows any deceleration.

The Bottom Line

The investment case for MSFT today is not that the stock is cheap. It is that the market spent a year pricing Microsoft as a company that could not convert AI spending into revenue, and the July 29 report proved that framing wrong. Azure’s acceleration to 43% growth, the landmark $100 billion annual Azure revenue milestone, and record commercial RPO gave investors concrete evidence that Microsoft’s AI infrastructure investments are generating accelerating returns at scale.

At roughly $492, with a $678 billion revenue backlog behind it, MSFT offers the combination this publication looks for: verified earnings momentum, institutional conviction, and a catalyst that changed the fundamental story rather than just the price. The risk is that 30 days of buyers have already captured the easy move. The opportunity is that the earnings revision cycle, from a company compounding EPS above 30%, has only just begun.

Post navigation

Previous: A 50/50 September: How to Position Every Asset Class
Next: Workday posted its fifth straight EPS beat

Related Stories

135e38d2-9ba5-4799-85f1-67ac540fbf1a
  • Business

Lam Research’s Perfect Quarter Wasn’t Enough. That’s the Problem.

Editor October 22, 2026
58d6de49-2c33-4824-8b08-3d3c63ddc444
  • Business

China’s Export Surge Has a January Problem

Editor October 14, 2026
8e5c5bec-8c89-4ae3-a894-1477436daaf2
  • Business

J&J Has a Tariff Shield Most Drugmakers Don’t

Editor October 13, 2026

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Want More Market News?
Add your email address below to get up to date market news and more!
By submitting your email address, you'll receive a free subscription to Options Trading Report newsletter (Privacy Policy). These newsletters are completely free - and always will be. You will also receive occasional offers about products and services available to you from our affiliates. You can unsubscribe at any time.

Recent Posts

  • The KOSPI’s 3.52% Drop Is Now Inside the Bank of Korea
  • AstraZeneca’s Kidney Readout. The Real Question Is What Options Didn’t Do.
  • 5 seconds
  • Lam Research’s Perfect Quarter Wasn’t Enough. That’s the Problem.
  • [Report] The 11-Hour Options Guide for Beginners – Trade and Ticker Included
  • Linde’s Hydrogen Steel Play Has CBAM Behind It
  • Netflix Fell Nearly 6% After Hours. Options Said 9.6%.

Search

Categories

  • Business
  • Economy
  • Market News
  • Newsletters
  • Top News

You may have missed

b2f7cc31-8932-4738-82ce-a307fd428d38
  • Top News

The KOSPI’s 3.52% Drop Is Now Inside the Bank of Korea

Editor October 22, 2026
229d6af6-172c-47fd-a5ac-fe6670a2b3d3
  • Newsletters

AstraZeneca’s Kidney Readout. The Real Question Is What Options Didn’t Do.

Editor October 22, 2026
121d2608-2202-4aa0-87db-b8015f5eda99
  • Newsletters

5 seconds

Editor October 22, 2026
135e38d2-9ba5-4799-85f1-67ac540fbf1a
  • Business

Lam Research’s Perfect Quarter Wasn’t Enough. That’s the Problem.

Editor October 22, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service/Use Agreement
  • Contact Us
Copyright 2026 © All rights reserved | Options Trading Report | optionstradingreport.com SITE_OK
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}